Message #4 From:
NewsBot Date: October 23, 2006 05:00:00 AM
BIOS News BioScrip to Report Third Quarter Earnings on November 7th
ELMSFORD, N.Y.--(BUSINESS WIRE)--BioScrip, Inc. (Nasdaq: BIOS) today announced that it will report
its third quarter earnings for the period ended September 30, 2006
before market open on November 7, 2006.
The Company will host a conference call to discuss results on November 7th
at 10:00 AM EST. Interested parties may participate in the conference
call by dialing 800-731-1404 (US), or 415-537-1905 (International) 5-10
minutes prior to the start of the call. A replay of the conference call
will be available from 12:00 PM EST on November 7th
through 12:00 PM EST on November 14th, by
dialing 800-633-8284 (US), or 402-977-9140 (International), and entering
reservation #21306985. Thereafter, a webcast of the conference call will
be available in the investors section of the BioScrip website at www.bioscrip.com.
About BioScrip, Inc.
BioScrip provides comprehensive pharmaceutical care solutions. We
partner with healthcare payors, pharmaceutical manufacturers, government
agencies, physicians, and patients to deliver cost effective programs
that enhance the quality of patient life. We focus our products and
services in two core areas: Specialty medication distribution and
clinical management services, both nationally and community-based, and
Pharmacy Benefit Management services. Our specialty medication
distribution capabilities include condition-specific clinical management
programs tailored to improve the care of individuals with complex health
conditions such as HIV/AIDS, Cancer, Infusion IVIG, Hepatitis C,
Rheumatoid Arthritis, Multiple Sclerosis, and Transplantation. Our
complete pharmacy benefit management programs include customized benefit
plan design, pharmacy network management and sophisticated reporting
capabilities that deliver improved clinical and economic outcomes. In
addition, we have 36 locations including community and infusion
pharmacies in major metropolitan markets across the U.S., providing
nationwide access and clinical management capabilities in a high-touch
community-based environment.
Forward Looking Statements
This press release may contain statements which constitute forward
looking statements within the meaning of the Private Securities
Litigation Reform Act of 1995, including statements regarding the
intent, belief or current expectations of the Company, its directors, or
its officers with respect to the future operating performance of the
Company and our success with respect to the integration and
consolidation. Investors are cautioned that any such forward looking
statements are not guarantees of future performance and involve risks
and uncertainties, and that actual results may differ materially from
those in the forward looking statements as a result of various factors.
Important factors that could cause such differences are described in the
Company's periodic filings with the Securities and Exchange Commission.
